Neurometrix, INC Form 4 insider transactions

Director Joshua Horowitz reports the disposal of NeuroMetrix shares due to the merger with electroCore, where shares were converted into cash and contingent value rights.

Following the merger with electroCore, NeuroMetrix director David Goodman reports the disposal of common stock and restricted stock units, receiving cash and contingent value rights in return.

Director David Van Avermaete reports the disposal of common stock and restricted stock units due to the merger between NeuroMetrix, Inc. and electroCore, Inc.

Thomas T. Higgins, CFO of NeuroMetrix, reports the disposal of common stock and restricted stock units due to the merger with electroCore, Inc.

Director Nancy E. Katz reports the disposal of common stock and restricted stock units due to the merger between NeuroMetrix and electroCore, where shares were converted into cash and contingent value rights.

Following the merger with electroCore, NeuroMetrix CEO Shai Gozani reports the disposal of common stock and restricted stock units, receiving cash and contingent value rights in return.

Director Thomas T. Higgins reports the vesting of restricted stock units and subsequent tax withholding.

Director Shai Gozani of NeuroMetrix, Inc. reports the vesting of restricted stock units and subsequent transactions on April 1, 2025.

Director Thomas Higgins reports the vesting of restricted stock units and subsequent tax withholding.

Director Shai Gozani reports stock transactions related to vesting restricted stock units of NeuroMetrix, Inc.

Director Thomas Higgins reports stock transactions related to restricted stock units of NeuroMetrix, Inc.

Director Shai Gozani reports stock transactions related to restricted stock units of NeuroMetrix, Inc.

Director Joshua Horowitz files amended Form 4 to correct a previous error and reports acquisition of NeuroMetrix, Inc. stock.

Director Joshua Horowitz of NeuroMetrix, Inc. reports the acquisition of common stock and restricted stock units, along with a correction to a previous filing.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent transactions.

NeuroMetrix CEO Shai Gozani reports the vesting of restricted stock units and subsequent tax withholding.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent transactions.

NeuroMetrix's CEO, Shai Gozani, reports the vesting of restricted stock units and subsequent tax withholding.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

NeuroMetrix CEO Shai Gozani reports the vesting of restricted stock units and subsequent tax withholding.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent transactions.

NeuroMetrix CEO Shai Gozani reports the vesting of restricted stock units and subsequent tax withholding.

Director David Van Avermaete was granted 13,730 restricted stock units in NeuroMetrix, Inc. on May 22, 2024, vesting on the earlier of the 2025 annual meeting or a change in control.

Director David Goodman of NeuroMetrix, Inc. was granted 13,730 restricted stock units on May 22, 2024, vesting on the earlier of the 2025 annual meeting or a change in control.

Director Nancy E. Katz was granted 13,730 restricted stock units in NeuroMetrix, Inc. on May 22, 2024, vesting on the earlier of the 2025 annual meeting or a change in control.

Bradley M. Fluegel, a director of NeuroMetrix, Inc., was granted 13,730 restricted stock units on May 22, 2024, vesting on the earlier of the 2025 annual meeting or a change in control.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

NeuroMetrix CEO Shai Gozani reports the vesting of restricted stock units and subsequent tax withholding.

Director Bradley M. Fluegel reports the vesting of restricted stock units and subsequent stock transactions at NeuroMetrix, Inc.

Director David Van Avermaete reports the vesting and conversion of restricted stock units into common stock of NeuroMetrix, Inc.